NO20054533L - Oral insulinsammensetning og metoder for a lage og bruke den - Google Patents

Oral insulinsammensetning og metoder for a lage og bruke den

Info

Publication number: NO20054533L
Authority: NO; Norway
Prior art keywords: making; methods; mammal; oral insulin; insulin composition
Prior art date: 2003-03-04

Application number

NO20054533A

Other languages

English (en)

Norwegian (no)

Other versions

NO20054533D0 (no

Inventor

Vladimir Sabetsky

Original Assignee

Technology Dev Company Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-04

Filing date

2005-10-03

Publication date

2005-12-02

2005-10-03 Application filed by Technology Dev Company Ltd filed Critical Technology Dev Company Ltd

2005-10-03 Publication of NO20054533D0 publication Critical patent/NO20054533D0/no

2005-12-02 Publication of NO20054533L publication Critical patent/NO20054533L/no

Links

239000000203 mixture Substances 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
229940125395 oral insulin Drugs 0.000 title 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
241000124008 Mammalia Species 0.000 abstract 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
239000008280 blood Substances 0.000 abstract 2
210000004369 blood Anatomy 0.000 abstract 2
239000008103 glucose Substances 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
229920002307 Dextran Polymers 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
239000011859 microparticle Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Dispersion Chemistry (AREA)
Inorganic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20054533A 2003-03-04 2005-10-03 Oral insulinsammensetning og metoder for a lage og bruke den NO20054533L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US45124503P	2003-03-04	2003-03-04
US46760103P	2003-05-05	2003-05-05
US46901703P	2003-05-09	2003-05-09
US49509703P	2003-08-15	2003-08-15
PCT/IB2004/000933 WO2004078196A1 (fr)	2003-03-04	2004-03-04	Composition d'insuline a administration orale et ses procedes de production et d'utilisation.

Publications (2)

Publication Number	Publication Date
NO20054533D0 NO20054533D0 (no)	2005-10-03
NO20054533L true NO20054533L (no)	2005-12-02

Family

ID=32831112

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20054534A NO20054534L (no)	2003-03-04	2005-10-03	Leveringssystem for legemiddel og celleterapi
NO20054539A NO20054539L (no)	2003-03-04	2005-10-03	Langtidsvirkende injekterbar insulinpreparat og fremgangsmate for fremstilling og anvendelse derav
NO20054533A NO20054533L (no)	2003-03-04	2005-10-03	Oral insulinsammensetning og metoder for a lage og bruke den

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
NO20054534A NO20054534L (no)	2003-03-04	2005-10-03	Leveringssystem for legemiddel og celleterapi
NO20054539A NO20054539L (no)	2003-03-04	2005-10-03	Langtidsvirkende injekterbar insulinpreparat og fremgangsmate for fremstilling og anvendelse derav

Country Status (17)

Country	Link
US (5)	US7544656B2 (fr)
EP (3)	EP1454631A1 (fr)
JP (3)	JP2006519253A (fr)
KR (3)	KR20060015469A (fr)
AR (1)	AR046485A1 (fr)
AT (1)	ATE485051T1 (fr)
AU (3)	AU2004216908A1 (fr)
BR (3)	BRPI0408105A (fr)
CA (3)	CA2518148A1 (fr)
DE (1)	DE602004029630D1 (fr)
EA (3)	EA200501420A1 (fr)
EC (3)	ECSP056077A (fr)
MX (1)	MXPA05009493A (fr)
NO (3)	NO20054534L (fr)
PT (1)	PT1454630E (fr)
TW (1)	TW200529869A (fr)
WO (3)	WO2004078196A1 (fr)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7339033B2 (en) *	1998-06-26	2008-03-04	Genentech, Inc.	Pro1481
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
ATE385193T1 (de)	2002-03-20	2008-02-15	Mannkind Corp	Inhalationsgerät
DE602004029630D1 (de) *	2003-03-04	2010-12-02	Technology Dev Co Ltd	Injizierbare Insulinzubereitung mit Langzeitwirkung und Verfahren zur dessen Herstellung und Verwendung
CA2531988C (fr) *	2003-08-05	2016-06-28	Novo Nordisk A/S	Nouveaux derives de l'insuline
TW200603843A (en) *	2004-04-20	2006-02-01	Technology Dev Company Ltd	Tissue enhancement implant and method
DK1786784T3 (da)	2004-08-20	2011-02-14	Mannkind Corp	Katalyse af diketopiperazinsyntese
BRPI0514293B1 (pt)	2004-08-23	2022-07-19	Mannkind Corporation	Sistema microparticulado para distribuição de droga
FR2880272A1 (fr) *	2005-01-04	2006-07-07	Jean Marc Ruiz	Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication
CA2621786A1 (fr) *	2005-08-29	2007-03-08	Tuo Jin	Microparticules de polysaccharide contenant des agents biologiques, leur preparation et leurs applications
DK1928423T3 (en)	2005-09-14	2016-02-29	Mannkind Corp	A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces
JP4808785B2 (ja) *	2005-12-28	2011-11-02	ノボ・ノルデイスク・エー／エス	インスリン組成物および組成物の製造方法
SE529040C2 (sv)	2006-01-18	2007-04-17	Bows Pharmaceuticals Ag	Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
CA2643464C (fr)	2006-02-22	2018-09-04	Mannkind Corporation	Procede pour ameliorer les proprietes pharmaceutiques de microparticules comprenant de la dicetopiperazine et un agent actif
EP2069062A2 (fr) *	2006-10-06	2009-06-17	The President and Fellows of Harvard College	Auto-assemblage électrostatique de matériaux mené chimiquement
ES2744384T3 (es)	2007-06-13	2020-02-24	Novo Nordisk As	Formulación farmacéutica que comprende un derivado de insulina
EP2025334A1 (fr) *	2007-07-25	2009-02-18	OctoPlus Sciences B.V.	Systèmes d'administration de médicaments à libération prolongée pour une administration répétée
WO2011163272A1 (fr)	2010-06-21	2011-12-29	Mannkind Corporation	Système et procédé d'administration de médicament sous la forme d'une poudre sèche
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
CN106039494B (zh)	2008-06-13	2019-12-24	曼金德公司	干粉吸入器和用于药物输送的系统
BRPI0914308B8 (pt)	2008-06-20	2021-06-22	Mannkind Corp	sistema de inalação
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
FR2940802A1 (fr) *	2008-10-10	2010-07-09	Adocia	Complexe entre l'insuline humaine et un polymere amphiphile et utilisation de ce complexe pour la preparation d'une formulation d'insuline humaine rapide.
LT3228320T (lt)	2008-10-17	2020-03-10	Sanofi-Aventis Deutschland Gmbh	Insulino ir glp-1 agonisto derinys
EP2352513B1 (fr) *	2008-10-30	2016-09-14	Novo Nordisk A/S	Traitement du diabète à l'aide d'injections d'insuline avec une fréquence inférieure à une injection par jour
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
WO2010105094A1 (fr)	2009-03-11	2010-09-16	Mannkind Corporation	Appareil, système et procédé de mesure de résistance d'un inhalateur
US9018190B2 (en)	2009-03-27	2015-04-28	Adocia	Functionalized oligosaccharides
FR2943538B1 (fr) *	2009-03-27	2011-05-20	Adocia	Formulation a action rapide d'insuline recombinante humaine
MY186975A (en)	2009-06-12	2021-08-26	Mannkind Corp	Diketopiperazine microparticles with defined specific surface areas
US9068182B2 (en) *	2009-07-28	2015-06-30	Corning Incorporated	Synthetic polysaccharide microcarriers for culturing cells
HUP0900482A2 (en)	2009-08-03	2011-03-28	Cera Med Kft	Pharmaceutical formulation for oral administration
EP2496295A1 (fr)	2009-11-03	2012-09-12	MannKind Corporation	Appareil et méthode de simulation d'efforts d'inhalation
EP2498801B1 (fr)	2009-11-13	2018-01-24	Sanofi-Aventis Deutschland GmbH	COMPOSITION PHARMACEUTIQUE COMPRENANT desPro36Exendin-4(1-39)-Lys6-NH2 ET DE LA MÉTHIONINE
PL2498802T3 (pl)	2009-11-13	2015-06-30	Sanofi Aventis Deutschland	Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
AU2011202239C1 (en)	2010-05-19	2017-03-16	Sanofi	Long-acting formulations of insulins
SI2611458T1 (sl)	2010-08-30	2017-01-31	Sanofi-Aventis Deutschland Gmbh	Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
HRP20191793T1 (hr)	2010-10-27	2019-12-27	Novo Nordisk A/S	Liječenje dijabetesa melitusa injekcijama inzulina koje se primijenjuje u različitim intervalima injiciranja
MY180552A (en)	2011-04-01	2020-12-02	Mannkind Corp	Blister package for pharmaceutical cartridges
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (fr)	2011-06-17	2012-12-20	Mannkind Corporation	Microparticules de dicétopipérazine de capacité élevée
WO2013021346A2 (fr) *	2011-08-07	2013-02-14	Transgene Biotek Ltd	Nouveau procédé d'administration perorale d'insuline et de ses analogues pour une utilisation thérapeutique
HUE027989T2 (en)	2011-08-29	2016-11-28	Sanofi Aventis Deutschland	A pharmaceutical composition for use in glycemic control in patients with type 2 diabetes
AR087744A1 (es)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
JP6018640B2 (ja)	2011-10-24	2016-11-02	マンカインドコーポレイション	疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
US20130231281A1 (en)	2011-11-02	2013-09-05	Adocia	Rapid acting insulin formulation comprising an oligosaccharide
DK2872205T3 (en)	2012-07-12	2017-02-27	Mannkind Corp	DRY POWDER FORMAL ADMINISTRATION SYSTEM
US9157939B2 (en) *	2012-08-09	2015-10-13	Infineon Technologies Ag	System and device for determining electric voltages
WO2014066856A1 (fr)	2012-10-26	2014-05-01	Mannkind Corporation	Compositions et procédés de vaccin antigrippal inhalable
CN104902922B (zh)	2012-11-13	2017-12-12	阿道恰公司	包含经取代阴离子化合物的速效胰岛素制剂
KR102391750B1 (ko)	2013-03-15	2022-04-28	맨카인드 코포레이션	미세결정성 디케토피페라진 조성물 및 방법
EP3517122A1 (fr)	2013-04-03	2019-07-31	Sanofi	Traitement du diabète sucré par des formulations à action prolongée d'insulines
EP2991672A1 (fr)	2013-04-30	2016-03-09	Novo Nordisk A/S	Schéma d'administration d'un nouveau type
JP6200698B2 (ja) *	2013-06-18	2017-09-20	ニュートリー株式会社	嚥下造影検査食
EP3021834A1 (fr)	2013-07-18	2016-05-25	MannKind Corporation	Compositions pharmaceutiques en poudre sèche stables à la chaleur et procédés
US11446127B2 (en)	2013-08-05	2022-09-20	Mannkind Corporation	Insufflation apparatus and methods
WO2015148905A1 (fr)	2014-03-28	2015-10-01	Mannkind Corporation	Utilisation d'insuline à action ultrarapide
FR3020947B1 (fr)	2014-05-14	2018-08-31	Adocia	Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en)	2014-05-14	2017-10-24	Adocia	Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
RU2014120626A (ru) *	2014-05-22	2015-11-27	Владимир Андреевич Сабецкий	Инсулинсодержащий препарат пролонгированного действия
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
CN105617362B (zh) *	2014-10-27	2021-05-11	中国医学科学院药物研究所	一种新型的胰岛素－磷脂－壳聚糖自组装微粒载体及其制剂
CA2970200A1 (fr)	2014-12-12	2016-06-16	Sanofi-Aventis Deutschland Gmbh	Formulation contenant un rapport fixe d'insuline glargine/lixisenatide
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
FR3043557B1 (fr)	2015-11-16	2019-05-31	Adocia	Composition a action rapide d'insuline comprenant un citrate substitue
US10660941B2 (en)	2016-02-19	2020-05-26	Indian Institute Of Technology, Bombay	Orally administrable pharmaceutical preparation containing protein
RU2647466C1 (ru) *	2016-12-01	2018-03-15	Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ)	Способ получения нативного белка пролонгирующего действия в составе полимерных наносфер и резорбируемых микросфер для доставки
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
WO2021009027A1 (fr)	2019-07-12	2021-01-21	Novo Nordisk A/S	Formulation d'insuline à concentration élevée
KR20200056360A (ko)	2020-04-29	2020-05-22	김용원	자전거바퀴(회전자)와 바퀴덮개(고정자)에 설치하는 발전기
KR20200056359A (ko)	2020-04-29	2020-05-22	김용원	퀵보드 등 승용기구바퀴(회전자)에 설치되는 바퀴덮개(고정자)에 설치하는 발전기
KR20200056361A (ko)	2020-05-04	2020-05-22	김용원	발판보드에 설치하는 발전기
KR20200060307A (ko)	2020-05-06	2020-05-29	김용원	자전거와 리어 캐리어에 설치하는 발전장치들
KR20200060308A (ko)	2020-05-07	2020-05-29	김용원	수상보드에 설치하는 발전기
KR20200060309A (ko)	2020-05-08	2020-05-29	김용원	헬스차량에 설치하는 발전기
KR20200062092A (ko)	2020-05-11	2020-06-03	김용원	수차와 공기 컴프레서를 이용한 공기 터빈구조 발전기와 바퀴구조 발전기를 합한 발전기
KR20200061324A (ko)	2020-05-11	2020-06-02	김용원	보트에 설치하는 발전기
KR20200068614A (ko)	2020-05-26	2020-06-15	김용원	펠티어소자를 이용한 공기, 물 컨디션너 조절장치 내에 설치한 발전기
KR20200083393A (ko)	2020-06-16	2020-07-08	김용원	"공기 터빈구조 발전기"와 "바퀴구조를 합한 발전기"를 "발열소자를 이용한 발전기"와 적용 양방향 모터(양방향 프로펠러)를 양방향공기추진기(Propullor)와 결합 장착한 드론
KR20200088241A (ko)	2020-06-30	2020-07-22	김용원	역방향 모터(양방향 프로펠러)의 추진에 맞는 관성을 이기는 팬이 없는 양방향공기추진기(Propullor)를 장착한 드론
KR20200108392A (ko)	2020-08-31	2020-09-18	김용원	전동 오토바이 모터의 정격에 맞는 오토바이바퀴에 회전자와 물받이 고정자 발전기를 설치한 오토바이에 모터가 장착된 항공기 공기추진기(Propulsor)와 장착한 드론의 프로퓰러(Propullor)를 장착하는 제조기술)
EP4274663A4 (fr) *	2021-01-07	2024-10-16	Ramot at Tel-Aviv University Ltd.	Procédés et compositions pour la synthèse de mélanine
KR20210018367A (ko)	2021-01-26	2021-02-17	김용원	전동 오토바이에 설치한 모터가 장착된 항공기 공기추진기와 장착한 프로퓰러(Propullor)로 구성한 오토에어크라프트(Autoaircraft)
KR20210029730A (ko)	2021-02-22	2021-03-16	김용원	산사태에 대비, 대응하는 에어 레이어들 블록들이 형성된 거대장비들(에어 레이어들 블록들)
KR20210040852A (ko)	2021-03-24	2021-04-14	김용원	전동에어버스
KR20210043513A (ko)	2021-03-26	2021-04-21	김용원	전동에어버스에 설치하는 연기(분연), 재 포집장치
KR20210045369A (ko)	2021-03-31	2021-04-26	김용원	전기 에어 카
KR20210049046A (ko)	2021-04-13	2021-05-04	김용원	전기에어버스를 강풍, 태풍에 구조하는 보조날개와 보조출입문 장치
KR20210055643A (ko)	2021-04-27	2021-05-17	김용원	모터가 장착된 회전축에 다량의 회전자바퀴와 다량의 고정자바퀴발전기를 설치한 전동보드
KR20210072739A (ko)	2021-05-27	2021-06-17	김용원	의료용 전동보드
KR20210080293A (ko)	2021-06-11	2021-06-30	김용원	바퀴 사이 발전기 케이스
CN115702880B (zh) *	2021-08-12	2023-11-03	山东新时代药业有限公司	一种重组甘精胰岛素注射液及其制备工艺
KR20220016234A (ko)	2022-01-14	2022-02-08	김용원	공기추진기(공기펌프와 공기터빈)를 장착한 3륜 자전거
KR20220038026A (ko)	2022-02-24	2022-03-25	김용원	4합 공기터빈 : 공기터빈 축에 1. 인너 팬들의 인너 실린더와 2. 아웃터 팬들의 아웃터 실린더와 3. 양쪽 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들에 덕트팬들과 덕트흡입구와 4 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들의 3. 덕트팬들에 블레이드와 블레이드 외부 형틀
KR20220056159A (ko)	2022-04-04	2022-05-04	김용원	물탱크 내의 스팀집 슈퍼히터에 전력공급한 스팀공급으로 스팀터빈을 구동하는 것과 슈퍼히터로 스팀을 공급하는 스팀청소기에 발전기들을 설치하는 것과 공기터빈의 흡입구들의 공기필터들 설치와 펠티에소자를 이용한 냉온 공기배출과 얼음제조기 시스템
KR20220056835A (ko)	2022-04-18	2022-05-06	김용원	공기추진기(공기펌프와 여러 공기터빈들)들을 장착한 수상 자전거
KR20220076421A (ko)	2022-05-11	2022-06-08	김용원	공기추진기(공기펌프와 공기터빈들)들을 장착한 페달자전차
KR20220080053A (ko)	2022-05-27	2022-06-14	김용원	다중 에어 레이어 튜브보트
WO2024167359A1 (fr) *	2023-02-08	2024-08-15	주식회사 인벤테라	Agent de contraste pour vaisseau lymphatique sans contamination veineuse
KR20250070006A (ko)	2025-04-23	2025-05-20	김용원	수륙양용 전동보드

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4713249A (en) *	1981-11-12	1987-12-15	Schroeder Ulf	Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
SE8204244L (sv) *	1982-07-09	1984-01-10	Ulf Schroder	Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4963526A (en) *	1984-05-09	1990-10-16	Synthetic Blood Corporation	Oral insulin and a method of making the same
WO1987002704A1 (fr)	1985-10-22	1987-05-07	Eric Robinson	Procede pour immobiliser des cellules
PH30995A (en) *	1989-07-07	1997-12-23	Novartis Inc	Sustained release formulations of water soluble peptides.
USRE37950E1 (en) *	1990-04-24	2002-12-31	Atrix Laboratories	Biogradable in-situ forming implants and methods of producing the same
US5618531A (en) *	1990-10-19	1997-04-08	New York University	Method for increasing the viability of cells which are administered to the brain or spinal cord
US5840290A (en) *	1996-05-30	1998-11-24	University Of Florida Research Foundation	Injectable bio-active glass in a dextran suspension
US5783556A (en) *	1996-08-13	1998-07-21	Genentech, Inc.	Formulated insulin-containing composition
US6395302B1 (en) *	1996-11-19	2002-05-28	Octoplus B.V.	Method for the preparation of microspheres which contain colloidal systems
EP0941068B1 (fr) *	1996-11-19	2004-05-26	OctoPlus B.V.	Microparticules à libération contrôlée
EP0842657A1 (fr) *	1996-11-19	1998-05-20	OctoPlus B.V.	Microsphères pour la libération contrÔlée et procédés pour la préparation de telles microsphères
FR2764514B1 (fr) *	1997-06-13	1999-09-03	Biopharmex Holding Sa	Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
AU736846B2 (en)	1997-07-10	2001-08-02	University Of Florida Research Foundation, Inc.	Moldable bioactive compositions
US6194006B1 (en) *	1998-12-30	2001-02-27	Alkermes Controlled Therapeutics Inc. Ii	Preparation of microparticles having a selected release profile
US20020054914A1 (en) *	1999-02-03	2002-05-09	Tulin Morcol	Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
DK1183016T3 (da) *	1999-02-19	2004-08-09	Univ Utrecht	Stereokomplekse hydrogeler
FR2794649B1 (fr) *	1999-06-11	2003-04-11	Solutions	Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
AU773990B2 (en) *	1999-09-27	2004-06-10	Stryker Corporation	Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
EP1184032A1 (fr) *	2000-08-31	2002-03-06	OctoPlus B.V.	Hydrogels à base de dextranne
FR2814951B1 (fr)	2000-10-06	2003-01-17	Flamel Tech Sa	Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation
AU2001292527A1 (en)	2000-11-16	2002-05-27	Jagotech AB	Parenterally administrable microparticles
GB2374010B (en) *	2001-02-26	2004-12-29	Council Scient Ind Res	Novel vitamin B12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines
EP1270012A1 (fr) *	2001-06-21	2003-01-02	Pfizer Products Inc.	Utilisation d'insuline administrée par voie pulmonaire pour le traitement du diabète
DE602004029630D1 (de) *	2003-03-04	2010-12-02	Technology Dev Co Ltd	Injizierbare Insulinzubereitung mit Langzeitwirkung und Verfahren zur dessen Herstellung und Verwendung
SE529040C2 (sv) *	2006-01-18	2007-04-17	Bows Pharmaceuticals Ag	Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin

2004
- 2004-03-04 DE DE602004029630T patent/DE602004029630D1/de not_active Expired - Lifetime
- 2004-03-04 EP EP04251253A patent/EP1454631A1/fr not_active Withdrawn
- 2004-03-04 AU AU2004216908A patent/AU2004216908A1/en not_active Abandoned
- 2004-03-04 WO PCT/IB2004/000933 patent/WO2004078196A1/fr not_active Ceased
- 2004-03-04 CA CA002518148A patent/CA2518148A1/fr not_active Abandoned
- 2004-03-04 JP JP2006506422A patent/JP2006519253A/ja active Pending
- 2004-03-04 US US10/792,383 patent/US7544656B2/en not_active Expired - Fee Related
- 2004-03-04 EA EA200501420A patent/EA200501420A1/ru unknown
- 2004-03-04 US US10/792,376 patent/US20040234615A1/en not_active Abandoned
- 2004-03-04 CA CA002518143A patent/CA2518143A1/fr not_active Abandoned
- 2004-03-04 JP JP2006506401A patent/JP2006519840A/ja active Pending
- 2004-03-04 US US10/548,213 patent/US20110097385A1/en not_active Abandoned
- 2004-03-04 BR BRPI0408105-6A patent/BRPI0408105A/pt not_active IP Right Cessation
- 2004-03-04 EA EA200501421A patent/EA200501421A1/ru unknown
- 2004-03-04 AT AT04251251T patent/ATE485051T1/de not_active IP Right Cessation
- 2004-03-04 MX MXPA05009493A patent/MXPA05009493A/es active IP Right Grant
- 2004-03-04 WO PCT/IB2004/000961 patent/WO2004078197A1/fr not_active Ceased
- 2004-03-04 PT PT04251251T patent/PT1454630E/pt unknown
- 2004-03-04 KR KR1020057016506A patent/KR20060015469A/ko not_active Withdrawn
- 2004-03-04 EP EP04717199A patent/EP1603589A1/fr not_active Withdrawn
- 2004-03-04 EP EP04251251A patent/EP1454630B1/fr not_active Expired - Lifetime
- 2004-03-04 AU AU2004216909A patent/AU2004216909A1/en not_active Abandoned
- 2004-03-04 WO PCT/IB2004/000984 patent/WO2004078198A1/fr not_active Ceased
- 2004-03-04 EA EA200501422A patent/EA200501422A1/ru unknown
- 2004-03-04 BR BRPI0408100-5A patent/BRPI0408100A/pt not_active IP Right Cessation
- 2004-03-04 AR ARP040100691A patent/AR046485A1/es unknown
- 2004-03-04 BR BRPI0408097-1A patent/BRPI0408097A/pt not_active IP Right Cessation
- 2004-03-04 TW TW093105776A patent/TW200529869A/zh unknown
- 2004-03-04 AU AU2004216911A patent/AU2004216911A1/en not_active Abandoned
- 2004-03-04 KR KR1020057016544A patent/KR20060014027A/ko not_active Withdrawn
- 2004-03-04 KR KR1020057016543A patent/KR20060015472A/ko not_active Withdrawn
- 2004-03-04 CA CA002518136A patent/CA2518136A1/fr not_active Abandoned
- 2004-03-04 JP JP2006506415A patent/JP2006519252A/ja active Pending
2005
- 2005-10-03 NO NO20054534A patent/NO20054534L/no not_active Application Discontinuation
- 2005-10-03 NO NO20054539A patent/NO20054539L/no unknown
- 2005-10-03 NO NO20054533A patent/NO20054533L/no not_active Application Discontinuation
- 2005-10-04 EC EC2005006077A patent/ECSP056077A/es unknown
- 2005-10-04 EC EC2005006078A patent/ECSP056078A/es unknown
- 2005-10-04 EC EC2005006076A patent/ECSP056076A/es unknown
2010
- 2010-03-08 US US12/719,636 patent/US20100167985A1/en not_active Abandoned
- 2010-03-08 US US12/719,633 patent/US20100166855A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ECSP056076A (es)	2006-08-30
AU2004216908A1 (en)	2004-09-16
CA2518136A1 (fr)	2004-09-16
EP1454630A1 (fr)	2004-09-08
AU2004216909A1 (en)	2004-09-16
CA2518143A1 (fr)	2004-09-16
US20040234615A1 (en)	2004-11-25
WO2004078198A1 (fr)	2004-09-16
BRPI0408105A (pt)	2006-03-01
AR046485A1 (es)	2005-12-14
EA200501422A1 (ru)	2006-04-28
KR20060015469A (ko)	2006-02-17
US20100166855A1 (en)	2010-07-01
US20110097385A1 (en)	2011-04-28
US20100167985A1 (en)	2010-07-01
CA2518148A1 (fr)	2004-09-16
NO20054534L (no)	2005-11-29
JP2006519253A (ja)	2006-08-24
AU2004216911A1 (en)	2004-09-16
DE602004029630D1 (de)	2010-12-02
EA200501421A1 (ru)	2006-04-28
ATE485051T1 (de)	2010-11-15
EP1603589A1 (fr)	2005-12-14
PT1454630E (pt)	2010-12-15
WO2004078196A1 (fr)	2004-09-16
NO20054539D0 (no)	2005-10-03
TW200529869A (en)	2005-09-16
ECSP056077A (es)	2006-08-30
MXPA05009493A (es)	2006-08-11
KR20060014027A (ko)	2006-02-14
EP1454631A1 (fr)	2004-09-08
ECSP056078A (es)	2006-08-30
NO20054534D0 (no)	2005-10-03
JP2006519252A (ja)	2006-08-24
WO2004078197A1 (fr)	2004-09-16
BRPI0408097A (pt)	2006-02-14
BRPI0408100A (pt)	2006-03-01
NO20054539L (no)	2005-12-01
US7544656B2 (en)	2009-06-09
US20040234616A1 (en)	2004-11-25
NO20054533D0 (no)	2005-10-03
KR20060015472A (ko)	2006-02-17
EA200501420A1 (ru)	2006-04-28
EP1454630B1 (fr)	2010-10-20
JP2006519840A (ja)	2006-08-31

Publication	Publication Date	Title
NO20054533L (no)	2005-12-02	Oral insulinsammensetning og metoder for a lage og bruke den
WO2004071529A3 (fr)	2005-05-06	Utilisations d'anticorps contre le recepteur de facteur de croissance insulinoide i
ATE429430T1 (de)	2009-05-15	Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen
NO20074999L (no)	2007-12-03	Metode og preparat for behandling av perifere vaskulaere sykdommer
WO2007002572A3 (fr)	2007-09-20	Nattokinase pour reduire la viscosite du sang total
NO20073059L (no)	2007-07-19	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NO20090591L (no)	2009-02-06	Metabolisme modulatorer samt behandling av lidelser relatert dertil
EA200870393A1 (ru)	2009-04-28	Новые композиции для нарушений волос и способ получения композиций
NO20053537L (no)	2005-08-26	Preparater og fremgangsmater for forebyggelse og kontroll av insulinindusert hypoglycemi.
NO20053041L (no)	2005-09-02	Behandling av diabetes.
WO2009004995A1 (fr)	2009-01-08	Procédé de fixation et d'expression d'une substance physiologiquement active
DK2043637T3 (da)	2012-05-07	Fremgangsmåder og medikamenter til administrering af ibuprofen
TW200833367A (en)	2008-08-16	Pharmaceutical compositions and method for treating inflammation in cattle and other animals
WO2005027977A3 (fr)	2005-12-08	Compositions de diclofenac destinees au traitement d'affections cutanees
EP2298336A3 (fr)	2011-07-13	Promotion de la régénération épithéliale
NO20070174L (no)	2007-03-13	Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi
NO20065453L (no)	2007-01-17	Fenoksyalkykarboksylsyrederivater i behandlingen av inflammatoriske sykdommer.
WO2007018588A8 (fr)	2008-05-08	Composition pharmaceutique stable comprenant la forme iv de linézolide
WO2005062713A3 (fr)	2005-08-11	Produits a base de betterave sucriere
NO20075831L (no)	2008-01-18	Krystallinske faste og amorfe former av (-)- halofenat
SE0301947D0 (sv)	2003-07-01	New method and uses
WO2004069272A3 (fr)	2004-11-25	Combinaison d'adjuvants destinee a l'immunisation d'un mammifere et comprenant il et il12
NO20056005L (no)	2006-02-24	Terapautiske midler
WO2004073627A3 (fr)	2004-11-18	Methode et compositions therapeutiques pour administration topique
RU2003112906A (ru)	2004-11-20	Способ лечения акантолической пузырчатки

Legal Events

Date	Code	Title	Description
2011-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application